Health · 1 sources covering this

STAT+: Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more

A personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to a standard treatment

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more
A personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to a standard treatment
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/909cdb0c1ef1bc6481a4b1105518375a8670d1fc"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more"></iframe>

STAT+: Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more

How 1 sources are covering this

STAT+: Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more

More from Health

Anxiety builds over Medicaid work requirements

Will a macaque eat a grape sitting on a pile of poo? A study on germaphobia

STAT+: Treasury proposes major restrictions to U.S. investment in Chinese biotech sector

STAT+: AI drug firm Pathos raises $237 million, pushing valuation to $3 billion

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Pharmalittle: We&#8217;re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more

More from Health

Anxiety builds over Medicaid work requirements

Will a macaque eat a grape sitting on a pile of poo? A study on germaphobia

STAT+: Treasury proposes major restrictions to U.S. investment in Chinese biotech sector

STAT+: AI drug firm Pathos raises $237 million, pushing valuation to $3 billion

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more